Whitlingum, Gabriel

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Marson, A., Burnside, G., Appleton, R., Smith, D., Leach, J. P., Sills, G., Tudur-Smith, C., Plumpton, C., Hughes, D. A., Williamson, P., et al. (2021) · The Lancet

Epilepsy research and treatmentPharmacological Effects and Toxicity Studies

Cited by 208

Avoidant/Restrictive Food Intake Disorder and Autism Spectrum Disorder: Clinical Implications for Assessment and Management

Farag, F., Sims, A., Strudwick, K., Carrasco, J., Waters, A., Ford, V., Hopkins, J., Whitlingum, G., Absoud, M., & Kelly, V. B. (2022) · Developmental Medicine & Child Neurology

Child Nutrition and Feeding IssuesEating Disorders and Behaviors

Cited by 89